CYP2C19基因多态性和脂蛋白磷脂酶A2表达与急性冠脉综合征患者介入术后短期预后的相关性OA
Association of CYP2C19 gene polymorphisms and lipoprotein-associated phospholipase A2 expression with short-term outcomes after percutaneous coronary intervention in patients with acute coronary syndrome
目的 探讨CYP2C19基因多态性和脂蛋白磷脂酶A2(Lp-PLA2)水平对急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)术后短期预后的影响.方法 回顾性纳入2023年1月至2025年1月河南科技大学第一附属医院心内科收治的182例ACS患者.根据随访30 d的主要不良心血管事件(MACE)发生情况,比较MACE组(n=32)与非MACE组(n=150)的临床资料,检测CYP2C19基因型分布和Lp-PLA2水平,并采用Cox回归分析评估危险因素.结果 MACE组的PM基因型比例和Lp-PLA2水平显著高于非 MACE 组(P<0.05).Cox 回归分析表明,CYP2C19 PM 型(HR=4.225,95%CI:2.107~8.471)、Lp-PLA2(HR=3.380,95%CI:1.771~6.451)、高龄(HR=1.380,95%CI:1.103~1.726)及超敏 C 反应蛋白(hs-CRP)水平(HR=1.338,95%CI:1.131~1.583)是 MACE 的独立危险因素(P<0.05).结论 CYP2C19 PM基因型和Lp-PLA2高表达是PCI术后短期不良预后的独立危险因素,为临床风险分层和个体化抗血小板治疗提供重要依据.
Objective To investigate the associations of CYP2C19 gene polymorphisms and lipoprotein-associat-ed phospholipase A2(Lp-PLA2)levels with short-term outcomes after percutaneous coronary intervention(PCI)in patients with acute coronary syndrome(ACS).Methods A total of 182 patients with ACS who were admitted to the De-partment of Cardiology,the First Affiliated Hospital of Henan University of Science and Technology,from January 2023 to January 2025 were retrospectively enrolled.According to the occurrence of major adverse cardiovascular events(MACE)within 30 days after PCI,the patients were divided into a MACE group(n=32)and a non-MACE group(n=150).Clinical characteristics were compared between the two groups.CYP2C19 genotypes and Lp-PLA2 levels were deter-mined,and Cox regression analysis was performed to identify risk factors associated with MACE after PCI.Results The proportion of patients with the CYP2C19 poor metabolizer(PM)genotype and the Lp-PLA2 level were significantly high-er in the MACE group than in the non-MACE group(P<0.05).Cox regression analysis showed that the CYP2C19 PM genotype(HR=4.225,95%CI:2.107-8.471),Lp-PLA2 level(HR=3.380,95%CI:1.771-6.451),older age(HR=1.380,95%CI:1.103-1.726),and high-sensitivity C-reactive protein(hs-CRP)level(HR=1.338,95%CI:1.131-1.583)were independent risk factors for MACE after PCI in patients with ACS(P<0.05).Conclu-sion The CYP2C19 PM genotype and higher Lp-PLA2 levels are associated with poor short-term outcomes after PCI in patients with ACS and may serve as potential reference indicators for clinical risk stratification and individualized antiplate-let therapy.
赵劲东;韩延辉;贾静静;曲红培
河南科技大学临床医学院/河南科技大学第一附属医院心血管内科(河南洛阳 471003)河南科技大学临床医学院/河南科技大学第一附属医院心血管内科(河南洛阳 471003)河南科技大学临床医学院/河南科技大学第一附属医院心血管内科(河南洛阳 471003)河南科技大学临床医学院/河南科技大学第一附属医院心血管内科(河南洛阳 471003)
医药卫生
急性冠状动脉综合征CYP2C19基因多态性脂蛋白磷脂酶A2短期预后经皮冠状动脉介入治疗
acute coronary syndromeCYP2C19 gene polymorphismlipoprotein-associated phospholipase A2short-term prognosispercutaneous coronary intervention
《广东医学》 2026 (9)
1341-1345,5
河南省医学科技攻关计划联合共建项目(LHGJ20230462)
评论